Skip to main content
August 24, 2020
Michael E. Thase, MD, spoke at the 2020 Psych Congress Elevate conference on adjunctive and combination therapies for difficult-to-treat depression. Here, he answers some of the questions asked by attendees.
August 06, 2020
Psych Congress cochair Charles Raison, MD, a leading researcher in the field of immune-brain interactions, explains how increased inflammation may affect response to psychotherapy.
July 27, 2020
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses deprescribing, the process of tapering or stopping medication being taken by a patient, which he spoke about on the final day of Psych Congress Elevate.
July 27, 2020
During his session at Psych Congress Elevate, Andrew Penn, RN, MS, NP, CNS, APRN-BC, suggested a collaborative approach when treating patients who present with a self-diagnosis for their symptoms and a specific medication request.
July 27, 2020
At Psych Congress Elevate, Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discussed clinician burnout and using wellness practices as a possible antidote. In this podcast, she explores the same topic.
July 26, 2020
Psychedelic therapy unites two basic, and often opposing, views as to the best approach to mental health treatment, Robin Carhart-Harris, PhD, explained at the 2020 virtual Psych Congress Elevate conference.
July 26, 2020
Genetic testing may be a helpful tool in diagnosing autism and intellectual disability, but published data does not adequately support its use as a standard predictor of antidepressant response, James B. Potash, MD, MPH, said at Psych Congress Elevate.
July 26, 2020
Psych Congress cochair Charles Raison, MD, who presented a session on the impact inflammation has on mental health at Psych Congress Elevate, explains the health effects of chronic increased inflammation.
July 25, 2020
A panel of mental health experts at the opening session of Psych Congress Elevate emphasized the importance of looking beyond the negative effects of the COVID-19 pandemic, and instead to the opportunities it presents now and the positive change it could bring in the future.
July 25, 2020
With costs dropping, graphics improving, and an evidence base that is growing, virtual reality (VR) technology is positioned to play a bigger role in mental health care in the coming years.
Back to Top